ENTERA BIO LTD

Historical 13F Holders

Symbol
ENTX
CUSIP
M40527109
All holders as of
Q2 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for M40527109 since 12/18/2024, newest first.

Filer % of Class Filed
Vivo Opportunity Fund Holdings, L.P. 13G
6.9% 8/4/2026
Event 7/28/2026
Longitude Capital Partners V, LLC 13G
4.6% 8/4/2026
Event 7/28/2026
TCG Crossover GP III, LLC 13G
7.1% 8/4/2026
Event 7/28/2026
Seven Fleet Capital Management LP 13G
4.1% 8/4/2026
Event 7/28/2026
Biotechnology Value Fund L P 13D
10.0% 8/4/2026
Event 7/28/2026
Point72 Asset Management, L.P. 13G/A Amendment 1
2.6% 11/14/2025
Event 9/30/2025
Opko Health, Inc. 13G 8.1% 4/2/2025
Event 3/16/2025
Point72 Asset Management, L.P. 13G
6.8% 1/6/2025
Event 1/3/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 47.3 k $138 k
2026 Q2 28 10.7 M $19.0 M
2026 Q1 26 7.87 M $8.68 M
2025 Q4 22 9.34 M $18.1 M
2025 Q3 23 9.19 M $17.7 M
2025 Q2 20 10.2 M $19.4 M
2025 Q1 21 10.2 M $17.4 M
2024 Q4 16 7.49 M $15.9 M
2024 Q3 21 5.32 M $10.1 M
2024 Q2 16 5.29 M $9.75 M
2024 Q1 18 4.26 M $7.11 M
2023 Q4 13 4.06 M $2.44 M
2023 Q3 15 2.58 M $1.87 M
2023 Q2 14 2.57 M $2.17 M
2023 Q1 12 2.83 M $3.28 M
2022 Q4 16 3.05 M $416 k
2022 Q3 12 4.66 M $4.85 M
2022 Q2 13 4.92 M $6.54 M
2022 Q1 15 4.95 M $14.2 M
2021 Q4 19 5.66 M $15.9 M
2021 Q3 19 5.67 M $26.7 M
2021 Q2 22 5.11 M $30.6 M
2021 Q1 9 1.99 M $7.57 M
2020 Q4 6 1.86 M $2.01 M
2020 Q3 7 1.91 M $2.36 M
2020 Q2 6 1.95 M $3.42 M
2020 Q1 4 1.99 M $3.78 M
2019 Q4 4 1.92 M $3.99 M
2019 Q3 6 1.05 M $2.62 M
2019 Q2 7 1.07 M $3.49 M
2019 Q1 8 1.09 M $4.67 M
2018 Q4 7 1.03 M $3.10 M
2018 Q3 5 769 k $4.11 M
2018 Q2 3 725 k $4.57 M